Clinical Trial Update: Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients. [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the effectiveness and safety of double-dose valsartan monotherapy for hypertension in Chinese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 4 | Status: COMPLETED